Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for weight management.
The medical device firm's Modius technology uses low-level electrical...
Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...
Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology.
New institutional investors, including Sands Capital...
Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX).
Minneapolis-based Saluda raised A$230.8 million through...
JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system.
Results from the ALIGN-AR pivotal...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform.
Ivy integrates advanced imaging, AI and robotic...
AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...
Neurovalens, the Belfast-based neuro-technology company, has been granted approval by the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for...
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis software, setting the arrhythmia assessment tool up for...
Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology.
New institutional investors, including Sands Capital...
Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX).
Minneapolis-based Saluda raised A$230.8 million through...